“We have to do more to help people achieve the technical endpoint we see in the trial”

High-profile venous specialists discuss developments in pulmonary embolism (PE) treatment space during CX 2026, touching on the HI-PEITHO, STORM-PE, PEERLESS and PEERLESS 2 trials. Watch the full roundtable discussion here.